: Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise
A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.
Some sectors are more likely to pick up hiring as borrowing costs fall. Here’s what that could look like.
The Federal Reserve finally gave stock-market investors what they wanted this week by cutting interest rates for the first time...
This summer, shares of Amazon.com Inc., Microsoft Corp. and Nvidia Corp. each took a hit after the technology giants reported...
Many 5% CDs are going away in the weeks after the Fed’s first interest-rate cut. Some have already disappeared.
September has historically been the worst month for U.S. stocks — but not this year